☆ 4.6 Review

The Disease Modification Conundrum in Parkinson's Disease: Failures and Hopes

FRONTIERS IN AGING NEUROSCIENCE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Neurosciences

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

M. Judith Peterschmitt et al.

Summary: This study evaluated the pharmacology, safety, and tolerability of the glucosylceramide synthase inhibitor venglustat in patients with Parkinson's disease and GBA mutations. The results showed favorable safety and tolerability of venglustat in both Japanese and non-Japanese participants, with target engagement achieved in cerebrospinal fluid.

JOURNAL OF PARKINSONS DISEASE (2022)

添加到收藏夹

Article Clinical Neurology

Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD)

Ruth B. Schneider et al.

Summary: The study aims to conduct long-term follow-up of Parkinson's disease clinical trial participants through virtual means, compare different assessment methods, and explore new digital markers. Results show that the majority of participants successfully downloaded the smartphone application and completed online patient-reported outcomes, indicating the feasibility of conducting a large-scale international virtual observational study.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

添加到收藏夹

Review Neurosciences

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations

Tiago A. Mestre et al.

Summary: The studies on PD subtypes have methodological shortcomings and questionable clinical applicability. Most studies did not achieve the highest rating on methodological quality checklists. The clinical importance of differences between subtypes and their potential treatment implications were rated poorly, indicating a need for new approaches that acknowledge individual-level heterogeneity and personalized medicine.

JOURNAL OF PARKINSONS DISEASE (2021)

添加到收藏夹

Review Neurosciences

Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Luca Muzio et al.

Summary: Microglia are resident macrophages of the central nervous system, playing a crucial role in immune defense in the brain. They support cell proliferation of neural precursors during brain development and preserve the integrity of neuronal circuits by sculpting synapses in post-natal life. Their functions change after CNS injury, but the precise role in neurological disorders is still not fully understood. There is evidence suggesting that regulating microglia functions could be a potential strategy for future therapies in neurodegenerative disorders such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

FRONTIERS IN NEUROSCIENCE (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial

Michael A. Schwarzschild et al.

Summary: In this randomized clinical trial, treatment with oral inosine for up to 2 years did not slow the progression of Parkinson disease in early stage patients. The study found that there was no significant difference in clinical disease progression between the inosine group and the placebo group.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Book Review Neurosciences

Synuclein and the Coelacanth: The Molecular and Evolutionary Origins of Parkinson's Disease

Alberto J. Espay et al.

JOURNAL OF ALZHEIMERS DISEASE (2021)

添加到收藏夹

Article Clinical Neurology

Seeking progress in disease modification in Parkinson disease

Codrin Lungu et al.

Summary: Lessons from past attempts and other fields can inform future research priorities in Parkinson's disease, including the development of biomarkers, refinement of patient populations, novel trial designs, and improved collaborations between stakeholders.

PARKINSONISM & RELATED DISORDERS (2021)

添加到收藏夹

Review Clinical Neurology

Seven Solutions for Neuroprotection in Parkinson's Disease

David Devos et al.

Summary: In the development of neuroprotective drugs for Parkinson's disease (PD), it is important to target specific patients, combine multiple treatments, establish early interventions and improve biomarkers, customize drugs, prioritize repurposed drugs, and adapt preclinical models with translational biomarkers.

MOVEMENT DISORDERS (2021)

添加到收藏夹

Review Medicine, General & Internal

Diagnosis and Treatment of Parkinson Disease A Review

Melissa J. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Clinical Neurology

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease

Susanne A. Schneider et al.

JOURNAL OF NEUROLOGY (2020)

添加到收藏夹

Review Clinical Neurology

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Alberto J. Espay et al.

NEUROLOGY (2020)

添加到收藏夹

Review Neurosciences

Deep Phenotyping of Parkinson's Disease

E. Ray Dorsey et al.

JOURNAL OF PARKINSONS DISEASE (2020)

添加到收藏夹

Review Medicine, General & Internal

Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization

Oxana P. Trifonova et al.

DIAGNOSTICS (2020)

添加到收藏夹

Article Clinical Neurology

Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy

Tosha Williams et al.

BRAIN COMMUNICATIONS (2020)

添加到收藏夹

Article Medicine, General & Internal

Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol

Julia C. Greenland et al.

BMJ OPEN (2020)

添加到收藏夹

Article Clinical Neurology

Digital phenotyping in Parkinson's disease: Empowering neurologists for measurement-based care

Roongroj Bhidayasiri et al.

PARKINSONISM & RELATED DISORDERS (2020)

添加到收藏夹

Review Clinical Neurology

The importance of preclinical diagnostics in Parkinson disease

Sneha Mantri et al.

PARKINSONISM & RELATED DISORDERS (2019)

添加到收藏夹

Article Clinical Neurology

A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

Alberto J. Espay et al.

MOVEMENT DISORDERS (2019)

添加到收藏夹

Review Clinical Neurology

Using wearables to assess bradykinesia and rigidity in patients with Parkinson's disease: a focused, narrative review of the literature

Itay Teshuva et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease

Seung Pil Yun et al.

NATURE MEDICINE (2018)

添加到收藏夹

Review Geriatrics & Gerontology

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease

Xian-Si Zeng et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

添加到收藏夹

Review Neurosciences

Animal models of neurodegenerative diseases

Ted M. Dawson et al.

NATURE NEUROSCIENCE (2018)

添加到收藏夹

Article Immunology

All (animal) models (of neurodegeneration) are wrong. Are they also useful?

Richard M. Ransohoff

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

添加到收藏夹

Article Clinical Neurology

Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

E. Ray Dorsey et al.

LANCET NEUROLOGY (2018)

添加到收藏夹

Review Neurosciences

The Emerging Evidence of the Parkinson Pandemic

E. Ray Dorsey et al.

JOURNAL OF PARKINSONS DISEASE (2018)

添加到收藏夹

Review Clinical Neurology

Biomarker-Driven Phenotyping in Parkinson's Disease: A Translational Missing Link in Disease-Modifying Clinical Trials

Alberto J. Espay et al.

MOVEMENT DISORDERS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain

Poonam Thakur et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

添加到收藏夹

Review Neurosciences

The MPTP Story

J. William Langston

JOURNAL OF PARKINSONS DISEASE (2017)

添加到收藏夹

Article Neuroimaging

Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images

Arman Rahmim et al.

NEUROIMAGE-CLINICAL (2017)

添加到收藏夹

Article Clinical Neurology

Long-term effects of rasagiline and the natural history of treated Parkinson's disease

Olivier Rascol et al.

MOVEMENT DISORDERS (2016)

添加到收藏夹

Review Clinical Neurology

Four Pioneers of L-dopa Treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr

Andrew J. Lees et al.

MOVEMENT DISORDERS (2015)

添加到收藏夹

Review Neurosciences

The Parkinson Progression Marker Initiative (PPMI)

Kenneth Marek et al.

PROGRESS IN NEUROBIOLOGY (2011)

添加到收藏夹

Article Medicine, Research & Experimental

The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies

Christopher G. Goetz

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)

添加到收藏夹

Article Clinical Neurology

Screening potential therapies - Lessons learned from new paradigms used in Parkinson disease

Barbara C. Tilley et al.

STROKE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.